There sure is a potential for a pathway to a takeover and/or approval now and analyst should start getting PTLA on their watchlist.
PTLA is on the verge of great things with PFE and other huge companies that its partnered with. Its a no brainer for a takover and/or approval of its many drugs that even some are on FDA fast track.
PTLA has some of the greatest potential and is partnered with at least 6 huge companies as BMY. It should be a no brainer of a takeover and/or approval of one of its many drugs coming very soon.
Its a little unknown company that has something special.
Look it up. Its too much medical for me but my wife found this gem and was just so excited to be that I seen that amazement in her because she is a nurse and I knew she was on something good.
Look at PTLA and if you can understand like I did not at first until my wife explained who did find this great find. Its a huge win for the medical field for both surgeons and patience.
what are people thinking and no wonder why so many people are out. cnbc, analyst and all media are just talk and no more. take your own thoughts and the more common sense will be there.
Ask anyone in the medical field of PTLA prospects. It is working with BMY and PFE currently.
Phase 3 in progress and remarks of completion with results will be announced soon
This company has some great medical upcoming surprises coming and could be bought before approved. Its so important in the medical field to use for surgery that approval would be great but earnings will be much better.
Back in the day when the Feds announced a raise in interest rates, a higher amount actually brought the market a lot higher that day ( an improved economy) and than the investors figured it out and realization came in and the market sold off. There are millions more investors involved today and there just as hawkish as the Feds. Its a lot faster thinking market today but does not seem to be as smart. The media easily influences the investors in which I too am at fault.The second or third Feds announcement will probably be the one.